The Fund Grade · free · no account needed
What grade does SCGVX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-09-01
Sands Capital Global Growth Fund Investor Shares
#45 of 440 graded active funds · growth · large segment peer group
The point · specialist footprint
SCGVX puts more of its book behind proven specialists than 93% of graded funds.
Bottom 20%
Bottom 40%
Middle
Top 40%
● Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8 points per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice
The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
Conviction exposure
49.6%
of the book in specialist-converged names
Late-stage weight
15%
of the book in Crowded or Fading names
Active share
89%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book — top names by stage · as of 2026-09-09
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
Sands Capital Global Growth Fund earns an A grade and ranks 45th out of 440 graded funds, with nearly half its assets backed by specialist investors. The standout story is a 9.6% position in NVDA at the Early Conviction stage, alongside early-stage bets on AMZN and NET, though specialists are visibly stepping back from ISRG, CSL, and ONON.
→ Monitor the Fading signals in ISRG, CSL, and ONON closely, as specialist exits often precede broader price weakness.
→ Note that NVDA at 9.6% in Early Conviction is the fund's strongest specialist-backed conviction; watch for any stage change.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.
The evidence base updates this week.
The specialists — not the whales — are already positioned for what comes next. Stop finding out last.
Create your free accountNo card required · open the feed in 30 seconds